Algert Global LLC Purchases New Holdings in Healthpeak Properties, Inc. (NYSE:DOC)

Algert Global LLC bought a new stake in Healthpeak Properties, Inc. (NYSE:DOC - Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm bought 211,616 shares of the real estate investment trust's stock, valued at approximately $4,289,000.

Other institutional investors have also recently added to or reduced their stakes in the company. Alyeska Investment Group L.P. increased its position in Healthpeak Properties by 160.5% during the fourth quarter. Alyeska Investment Group L.P. now owns 2,591,773 shares of the real estate investment trust's stock worth $52,535,000 after buying an additional 1,596,740 shares in the last quarter. Aristotle Capital Boston LLC purchased a new position in shares of Healthpeak Properties in the 4th quarter worth $3,075,000. Mercer Global Advisors Inc. ADV grew its holdings in shares of Healthpeak Properties by 29.4% during the 4th quarter. Mercer Global Advisors Inc. ADV now owns 38,379 shares of the real estate investment trust's stock worth $778,000 after purchasing an additional 8,726 shares during the period. Kapitalo Investimentos Ltda purchased a new position in shares of Healthpeak Properties in the 4th quarter valued at $46,000. Finally, Northern Trust Corp lifted its stake in shares of Healthpeak Properties by 32.6% during the fourth quarter. Northern Trust Corp now owns 10,526,223 shares of the real estate investment trust's stock worth $213,367,000 after purchasing an additional 2,590,530 shares in the last quarter. Hedge funds and other institutional investors own 93.57% of the company's stock.

Healthpeak Properties Trading Up 0.6 %

Shares of Healthpeak Properties stock traded up $0.11 during trading on Friday, reaching $17.50. 4,245,778 shares of the company were exchanged, compared to its average volume of 4,952,796. The firm has a market capitalization of $12.16 billion, a price-to-earnings ratio of 50.00, a P/E/G ratio of 2.17 and a beta of 1.05. The business has a 50-day moving average price of $19.08 and a 200-day moving average price of $20.24. The company has a quick ratio of 1.35, a current ratio of 1.35 and a debt-to-equity ratio of 0.96. Healthpeak Properties, Inc. has a twelve month low of $17.21 and a twelve month high of $23.26.

Healthpeak Properties (NYSE:DOC - Get Free Report) last issued its quarterly earnings data on Thursday, April 24th. The real estate investment trust reported $0.46 EPS for the quarter, hitting analysts' consensus estimates of $0.46. The business had revenue of $702.89 million for the quarter, compared to analyst estimates of $690.76 million. Healthpeak Properties had a net margin of 9.00% and a return on equity of 2.61%. The firm's quarterly revenue was up 15.9% on a year-over-year basis. During the same period last year, the business posted $0.45 earnings per share. Sell-side analysts anticipate that Healthpeak Properties, Inc. will post 1.86 EPS for the current fiscal year.

Healthpeak Properties Announces Dividend

The business also recently announced a dividend, which was paid on Wednesday, April 30th. Investors of record on Friday, April 18th were issued a dividend of $0.1017 per share. This represents a dividend yield of 6.5%. The ex-dividend date of this dividend was Thursday, April 17th. Healthpeak Properties's payout ratio is 305.00%.

Insider Buying and Selling

In other news, Director John T. Thomas purchased 4,200 shares of the stock in a transaction on Monday, April 28th. The stock was purchased at an average price of $17.84 per share, for a total transaction of $74,928.00. Following the acquisition, the director now owns 813,566 shares in the company, valued at $14,514,017.44. This trade represents a 0.52 % increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Scott M. Brinker bought 11,337 shares of the stock in a transaction on Monday, April 28th. The stock was acquired at an average price of $17.68 per share, with a total value of $200,438.16. Following the completion of the acquisition, the chief executive officer now owns 201,863 shares of the company's stock, valued at $3,568,937.84. This represents a 5.95 % increase in their position. The disclosure for this purchase can be found here. 0.23% of the stock is currently owned by insiders.

Analysts Set New Price Targets

DOC has been the topic of a number of recent research reports. Wedbush reduced their target price on shares of Healthpeak Properties from $24.00 to $22.00 and set an "outperform" rating on the stock in a research report on Monday, April 28th. StockNews.com lowered Healthpeak Properties from a "hold" rating to a "sell" rating in a research report on Thursday, May 1st. Morgan Stanley upgraded Healthpeak Properties from an "equal weight" rating to an "overweight" rating and set a $25.00 price objective for the company in a research note on Wednesday, January 15th. Robert W. Baird decreased their price target on shares of Healthpeak Properties from $24.00 to $22.00 and set an "outperform" rating for the company in a research report on Tuesday, April 29th. Finally, Scotiabank decreased their price objective on shares of Healthpeak Properties from $24.00 to $23.00 and set a "sector outperform" rating for the company in a report on Friday, February 28th. One equities research analyst has rated the stock with a sell rating, three have given a hold rating and nine have assigned a buy rating to the company. According to data from MarketBeat, the company has a consensus rating of "Moderate Buy" and an average price target of $23.42.

Healthpeak Properties Profile

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.